Skip to main content
. 2022 Apr 18;13:836954. doi: 10.3389/fneur.2022.836954

Table 2.

Clinical characteristics of three affected patients.

IV-1 IV-4 IV-6
Sex/Age M/22 y 11 months M/13 y 8 months F/4 y 10 months
Age at examination 19 y 9 y 2 y
Past medical history Hypotonia in infancy Hypotonia in infancy Hypotonia in infancy
Seizure
Onset age 5 y 6 months 3 months
Type Generalized tonic-clonic
Atypical absence
Focal impaired awareness
Secondary generalized tonic
Generalized tonic
Focal impaired awareness
Frequency 10–15/day at the beginning → 1–2/month at the time of visiting 1/month Under control with medication
Antiseizure medications Valproate, clonazapem, lacosamide, levetiracetam Valproate Levetiracetam
Delayed development Severe global delay Severe global delay Moderate motor and adaptive delay
Severe language delay
Psychosocial state Severe intellectual disability Hyperactivity Severe intellectual disability
Hyperactivity
Severe cognitive dysfunction Behavioral problem is not proved yet.
Abnormal findings on neurologic examination Slurred speech Clumsy hand movement Mild ataxic gait Slurred speech
Clumsy hand movement
Mild ataxic gait
Hypotonia
Mild ataxic gait
Disease course Static Static Progressive → Static
EEG results Sharp wave in Rt. or Lt. F region Ictal—rhythmic theta in both FC regions Spike in Rt. or both F regions
Spike in Rt. T region
Polyspikes in Rt. hemisphere
Spike in Lt. or both FC regions
Brain MRI findings Mild cerebral atrophy HSI in the bilateral globus pallidi and dentate nucleus Mild cerebral atrophy
HSI in the bilateral globus pallidi and dentate nucleus
Perisylvian polymicrogyria
HSI in the bilateral globus pallidi and dentate nucleus

F, frontal; FC, fronto-central; T, temporal; EEG, electroencephalography; MRI, magnetic resonance imaging; HSI, high signal intensity.